Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐RLisa Giulino‐Roth, John P. Leonard, Tara J. O’Donohue et al.|British Journal of Haematology|2017Cited by 129
A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma.Emily K. Slotkin, William D. Tap, Scarlett Rodriguez et al.|Journal of Clinical Oncology|2022Cited by 14
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K. Slotkin, William D. Tap, Audrey Mauguen et al.|JCO oncology advances.|2025Cited by 3
OUTCOMES OF ADULTS, ADOLESCENTS, AND CHILDREN WITH PRIMARY MEDIASTINAL B‐CELL LYMPHOMA TREATED WITH DOSE‐ADJUSTED EPOCH‐R THERAPY: a MULTICENTER RETROSPECTIVE ANALYSISLisa Roth, John P. Leonard, Tara J. O’Donohue et al.|Hematological Oncology|2017Cited by 1